STAGE III COLON CANCER AJCC V8
Clinical trials for STAGE III COLON CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III COLON CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III COLON CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to stop aggressive colon Cancer's return
Disease control OngoingThis study is for people with a specific type of stage II or III colon cancer who have already had surgery and chemotherapy. It tests whether adding a new, targeted two-drug treatment after the standard care is better at keeping the cancer from coming back, compared to just watch…
Matched conditions: STAGE III COLON CANCER AJCC V8
Phase: PHASE2, PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Major trial aims to stop colon Cancer's return with Immune-Boosting drug
Disease control OngoingThis study is for people with stage III colon cancer that has a specific genetic feature (dMMR). It compares the standard chemotherapy treatment (FOLFOX) to that same chemotherapy plus an immunotherapy drug called atezolizumab. The goal is to see if adding the immunotherapy helps…
Matched conditions: STAGE III COLON CANCER AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for Tough-to-Treat colon cancer patients
Disease control OngoingThis early-stage trial is testing whether combining existing cancer drugs with a new experimental drug (LY3214996) can help control advanced colorectal cancer that has stopped responding to standard treatments. The study aims to find safe doses and see if these combinations can s…
Matched conditions: STAGE III COLON CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New Two-Drug attack on Tough-to-Treat colon cancer
Disease control OngoingThis study is testing a new two-drug combination for people with advanced colorectal cancer that has spread and is no longer responding to standard chemotherapy. The trial combines an experimental pill called SX-682, which aims to block tumor growth, with an existing immunotherap…
Matched conditions: STAGE III COLON CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Can an immunotherapy boost stop tough colon cancer?
Disease control OngoingThis study is for people with advanced colorectal cancer that has spread or cannot be removed by surgery and has a specific BRAF gene mutation. It tests if adding the immunotherapy drug nivolumab to two standard targeted drugs works better to control the cancer and stop it from g…
Matched conditions: STAGE III COLON CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Cancer's hidden cost: study tracks financial toll on patients
Knowledge-focused OngoingThis study aims to understand how cancer treatment affects patients' finances and employment. Researchers are following 565 people with early-stage colon or rectal cancer for two years, asking them to complete surveys about costs, work life, and quality of life. The goal is to me…
Matched conditions: STAGE III COLON CANCER AJCC V8
Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC